Wire · operational-macro
Paramount-Warner Merger Puts Remedy Design at the Center of Antitrust Review
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 27 July 2026 · Fusion42 review
The Paramount-Skydance acquisition of Warner Bros. Discovery faces divergent regulatory outcomes: European approval with structural remedies (divesting UIP stake, distribution restrictions), DOJ non-challenge, but US state attorneys general won a court pause pending Clayton Act review. Remedy design—not just approval—now determines whether mega-mergers close and under what conditions.
This Wire brief sits within Fusion42's coverage of Streaming & Media.
◆ ◆ The Wire takeaway
Remedy design now trumps regulatory clearance in mega-deal approval. One enforcer's fix—divestment, licence restrictions, monitoring—does not bind another, which means your exit may depend less on whether any single authority approves and more on whether you can satisfy every regulator's different fix for the same problem.
◆ Coverage
1 source · 27 Jul 2026
◆ Related on Wire
◆ Topics